12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Other News

Biota Pharmaceuticals infectious news

Biota said it will reduce headcount by about 30 (27%) to 80 over the "next several quarters" to save cash. The cuts will be concentrated on R&D functions dedicated to drug discovery, but will also come from other areas including general and administrative. Biota closed its facility in Rockville and expects to complete the relocation of its U.S. headquarters to Atlanta, Ga., next month. The company will shift its focus to its clinical-stage programs that it can independently advance into late-stage development from early stage research. Biota may also in-license, acquire, co-develop...

Read the full 437 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >